Startseite Exhaled breath analysis for early cancer detection: principle and progress in direct mass spectrometry techniques
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Exhaled breath analysis for early cancer detection: principle and progress in direct mass spectrometry techniques

  • Koffi Badjagbo

    Dr. Koffi Badjagbo graduated from the School of Applied Science, Université de Lomé in Togo. He undertook MSc studies and obtained a PhD in Analytical Chemistry at the Université de Montréal, Canada. Before becoming a Lecturer of Analytical Chemistry and Environmental Chemistry in the Université de Montréal in 2010 and then an Assistant Professor in 2012, he worked as an Associate Researcher for Phytronix Technologies and as a Researcher for the Laboratory of Environmental Chemistry, QC, Canada, for over 5 years. His research includes applications of direct mass spectrometry in bioanalytical chemistry and in atmospheric chemistry, development of direct real-time monitoring methods for volatile biomarkers in exhaled breath and for volatile organic compounds in ambient air.

    EMAIL logo
Veröffentlicht/Copyright: 30. Mai 2012
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Volatile biomarker analysis in exhaled breath is becoming one of the desirable strategies for cancer detection because it may offer a relatively inexpensive, rapid, and non-invasive screening method for early diagnosis. Breath analysis has attracted a considerable amount of scientific and clinical interest over the past decade. However, breath is not yet used for routine medical diagnostic purposes. Challenges faced in the development of breath analysis for cancer diagnosis include developing techniques that can measure biomarkers in exhaled breath at ultratrace levels, providing definitive evidence for their presence and for the relationship between the proposed biomarker and the underlying condition. Various analytical methods are used for the detection of breath biomarkers. Gas chromatography-based methods which involve sample collection, analyte preconcentration, desorption, and separation steps are the most popular. However, direct-sampling mass spectrometry techniques have been proven more reliable for air analysis without prior sample pretreatment or chromatographic separation. This review focuses on the most commonly used direct mass spectrometry methods for the direct online analysis of endogenous cancer biomarkers in exhaled breath, with particular attention to principle of detection, method performance, advantages, shortcomings, recent advances, and applications within health-related studies for cancer biomarkers research. The principle behind the science of breath analysis for cancer diagnosis is also discussed.


Corresponding author: Koffi Badjagbo, Department of Chemistry, Université de Montréal, CP 6128 Centre-ville, Montréal, H3C 3J7, QC, Canada Phone: +1 514 343-6111 ext. 3921

About the author

Koffi Badjagbo

Dr. Koffi Badjagbo graduated from the School of Applied Science, Université de Lomé in Togo. He undertook MSc studies and obtained a PhD in Analytical Chemistry at the Université de Montréal, Canada. Before becoming a Lecturer of Analytical Chemistry and Environmental Chemistry in the Université de Montréal in 2010 and then an Assistant Professor in 2012, he worked as an Associate Researcher for Phytronix Technologies and as a Researcher for the Laboratory of Environmental Chemistry, QC, Canada, for over 5 years. His research includes applications of direct mass spectrometry in bioanalytical chemistry and in atmospheric chemistry, development of direct real-time monitoring methods for volatile biomarkers in exhaled breath and for volatile organic compounds in ambient air.

Received: 2012-03-30
Accepted: 2012-05-01
Published Online: 2012-05-30
Published in Print: 2012-11-01

©2012 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Congress Abstracts
  2. 44th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology
  3. Masthead
  4. Masthead
  5. Editorials
  6. Tumor biomarkers: PSA and beyond
  7. Error reporting in transfusion medicine: an important tool to improve patient safety
  8. The measurement of 25-hydroxy vitamin D – an analytical challenge
  9. Reviews
  10. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers
  11. Exhaled breath analysis for early cancer detection: principle and progress in direct mass spectrometry techniques
  12. γ′ Fibrinogen as a novel marker of thrombotic disease
  13. Mini Review
  14. Revaluating serum ferritin as a marker of body iron stores in the traceability era
  15. Genetics and Molecular Diagnostics
  16. Association of PBEF gene polymorphisms with acute lung injury, sepsis, and pneumonia in a northeastern Chinese population
  17. General Clinical Chemistry and Laboratory Medicine
  18. Brazilian laboratory indicators program
  19. Error reporting in transfusion medicine at a tertiary care centre: a patient safety initiative
  20. Application of mathematical models of system uncertainty to evaluate the utility of assay calibration protocols
  21. 25-Hydroxyvitamin D testing: challenging the performance of current automated immunoassays
  22. Analytical validation of the Roche 25-OH Vitamin D Total assay
  23. The new Roche Vitamin D Total assay: fit for its purpose?
  24. Improvement of a prenatal screening program for trisomy 18 in the first trimester of gestation
  25. Stability of osteopontin in plasma and serum
  26. Is there a suitable point-of-care glucose meter for tight glycemic control? Evaluation of one home-use and four hospital-use meters in an intensive care unit
  27. Cancer Diagnostics
  28. Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses
  29. Detection of frequent ABCB1 polymorphisms by high-resolution melting curve analysis and their effect on breast carcinoma prognosis
  30. Cardiovascular Diseases
  31. The combined use of neutrophil gelatinase-associated lipocalin and brain natriuretic peptide improves risk stratification in pediatric cardiac surgery
  32. Association of the atherogenic index of plasma and oxidative stress status with weight gain during non-complicated pregnancy
  33. The high-sensitivity cardiac troponin T assay is superior to its previous assay generation for prediction of 90-day clinical outcome in ischemic stroke
  34. Letters to the Editor
  35. Evaluation of the cross-reactivity of 25-hydroxyvitamin D2 on seven commercial immunoassays on native samples
  36. Measurement of 25-hydroxyvitamin vitamin D by liquid chromatography tandem-mass spectrometry with comparison to automated immunoassays
  37. Analytical evaluation of a new automated protein binding assay to determine 25-hydroxyvitamin D concentrations
  38. Mindray BS-800M1: a new clinical chemistry system with a flexible technology meeting quality performances
  39. Association of urinary albumin and serum high molecular weight-adiponectin with metabolic syndrome in patients with essential hypertension
  40. Measurement of nitrite in plasma and serum: still a challenging analytical task
  41. Association between serum γ-glutamyltransferase and pulmonary dysfunction
  42. Serum ferritin concentrations predict incidence of metabolic syndrome in rural Korean adults
  43. Homocysteine, folic acid and vitamin B12 levels in females with severe acne vulgaris
Heruntergeladen am 21.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2012-0208/html
Button zum nach oben scrollen